Person

Keith D. Dawkins

Formerly EVP, Global Chief Med. Off., Boston Scientific

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$4.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 28, 2017BSXSale30,000$24.64$739K
Feb 7, 2017BSXSale80,783$25.21$2.0M
May 10, 2016BSXSale80,000$22.15$1.8M

SEC reporting-owner ID (CIK) 1492253 · all filings on EDGAR

Keith D. Dawkins | USBoard